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Six plants species (Harungana madagascariensis, Sapium ellipticum, Teclea nobilis, 
Pseudospondias microcarpa, Rauvolfia vomitoria and Psorospermum febrifugum) which are used 
in managing HIV/AIDS in Bukoba, Tanzania were screened for their antimicrobial effect on the 
selected representatives of infectious bacterial and fungal species. Gram-positive bacteria 
Streptococcus lactis, Gram-negative bacteria Klebsiella pneumoniae and a fungus Candida 
albicans were tested for their sensitivity to the treatment with selected plants extracts using disc 
diffusion and broth dilution techniques. Extracts of S. ellipticum, P. febrifegum and P. microcarpa 
demonstrated growth inhibition of S. lactis with the MIC ranging from 3.2 to 100 mg/ml. The 
extracts of S. ellipticum, P. febrifegum and T. nobilis demonstrated growth inhibition of K. 
pneumonia with the MIC ranging from 6.3 to 25 mg/ml. On the other hand, extracts of H. 
madagascariensis, P. microcarpa and R. vomitoria inhibited growth of C. albicans with the MIC 
ranging from 12.5 to 50 mg/ml. These results are very promising towards discovery of new 
antimicrobial drugs especially against neglected S. lactis, K. pneumoniae and invasive Candida 
infections and could explain the routine use of the plants’ infusions in traditional medicines in 
Bukoba against HIV/AIDS related illnesses.  
 




HIV/AIDS is a devastating syndrome 
accompanied by a severe decline in 
immunity, which gives rise to emergence of 
multiple opportunistic infections. 
Opportunistic infections are those infections 
that emerge when people have a 
compromised immunity such as in the case 
of HIV/AIDS infections (Mastromarino et 
al. 2013, Africa et al. 2014). 
 
The use of combination antiretroviral 
therapy (cART) in recent years has 
contributed greatly in the suppression of the 
virus and therefore increases in survival 
rates of patients (Greenberg et al. 2009, 
Buchacz et al. 2010, Tan et al. 2012, 
Iroezindu et al. 2013). cART targets the HIV 
life cycle leading to suppression of viral load 
and increase in CD4 cell count, helping the 
body in fighting opportunistic infections 
(Mocroft et al. 2013). Unfortunately, the use 
of cART does not eradicate the virus or the 
opportunistic infections from the infected 
host completely (Van Rie et al. 2011, Auld 
et al. 2013). For this reason, opportunistic 
infections such as Streptococcus lactis, 
Klebsiella pneumoniae and Candida species 
infection have remained a serious challenge 
in HIV/AIDS patients (Tan et al. 2012, 




Mocroft et al. 2013). These microorganisms 
are usually found on different body parts of 
healthy persons, however in cases of 
immunocompromised individuals, the 
microorganisms can cause several serious 
conditions including liver abscess, empyema 
(pus in lungs), endocarditis and chronic 
diarrhea, pneumonia, urinary tract 
infections, wound infections and blood 
infections (Burkitt and Watson. 2009, Kim 
et al. 2010, Arnold et al. 2012, Tzouvelekis 
et al. 2012, Duin et al. 2013, Munoz-Price et 
al. 2013, Karaaslan et al. 2016) 
 
There has been an increased drug resistance 
by many of the causative agents of 
opportunistic infections against the available 
standard antibiotics, giving rise to the use of 
alternative medicine to manage them. 
Several literature reports have indicated the 
use and importance of plant and natural 
products in managing opportunistic 
infections (Arekemase et al. 2011, Mathur et 
al. 2011, Dubey et al. 2011, Savithramma et 
al. 2011, Moshi et al. 2012, Sen and Barta 
2012,Kengni et al. 2013, Al-Terehi et al. 
2015,Tsobou et al. 2015). The great 
diversity in therapeutic properties make 
plant products to act as alternatives to 
synthetic antibiotics which over the years 
have faced resistance from super bugs 
(Jebashree et al. 2011). 
 
The plant species Harungana 
madagascariensis, Sapium ellipticum, 
Teclea nobilis, Pseudospondias microcarpa, 
Rauvolfia vomitoria and Psorospermum 
febrifugum are among the most widely used 
herbal medicines used in managing 
HIV/AIDS in Bukoba, Tanzania (Kisangau 
et al. 2007). From the best of our 
knowledge, there has never before been any 
scientific verification of the effectiveness of 
the infusions from the named plants against 
the bacteria S. lactis and K. pneumoniae.  
 
Therefore, in the current study, extracts were 
screened for their growth inhibition activity 
against S. lactis, K. pneumoniae and C. 
albicans. The findings of this study provide 
scientific verification of the therapeutic 
potential of the studied plants’ infusions in 
the management of opportunistic infections 
linked with HIV/AIDS in traditional 
medicines in Bukoba. 
 
MATERIALS AND METHODS 
Collection of plant material  
The plants samples which were collected 
and used in this study included Harungana 
madagascariensis (Stem bark), Sapium 
ellipticum (Stem bark), Teclea nobilis (Stem 
bark), Pseudospondias microcarpa (Stem 
bark), Rauvolfia vomitoria (Stem bark) and 
Psorospermum febrifegum (Leaves). Field 
collection and identification of the plants 
was done in April 2014. Voucher specimen 
(Table 1) were coded and kept in the 
herbarium of the Department of Botany at 
University of Dar es Salaam (UDSM). 
 
Processing and extraction of plant material 
The collected plant material was chopped 
into small pieces and then air dried for a 
period of up to twenty one days. The dried 
plant materials were ground into fine 
powder using NATIONAL SUPER
®
 mixer 
grinder [MX-119] (Emerging planet India 
Ltd., Coimbatore 641011, India). 
 
To prepare aqueous extracts; the powder 
(400g) was soaked in distilled water for 48hr 
at room temperature with stirring after every 
12 hr. The mixture was then decanted and 
filtered using Buchner flask (Vacuubrand 
GMBH
+
CO Germany) and filtrate was 
centrifuged at 1000rpm for 5 minutes to 
remove any remaining particulates. This 
filtrate was then freeze dried using 
ScanVavCoolsafe, LaboGene™ to obtain 
crude aqueous extract. The aqueous extracts 
were put in clean glass bottles and stored at 
4
o
C until the day of use.  
 
To prepare ethyl acetate extracts; the 
obtained powder of dried plant materials 
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was soaked in ethyl acetate for a period of 
48 hours. The mixture was then filtered 
using Buchner flask (Vacuubrand 
GMBH
+
CO Germany) and filtrate was then 
concentrated on the rotary evaporator (R-
210 BUCHI, Switzerland) at 45
o
C, 100mbar 
pressure. The obtained ethyl acetate crude 
extracts were put in clean and labeled pre-
weighed glass bottles and stored at 4
o
C until 
the day of use.  
 
Test microorganisms  
Three test microorganisms used were Gram-
positive bacteria Streptococcus lactis (DSM 
20481), Gram-negative bacteria Klebsiella 
pneumonia (DSM 681) and the yeast 
Candida albicans (DSM 1665), all obtained 
from the microbial strains library of the 
Department of Molecular Biology and 
Biotechnology (MBB), UDSM 
 
Preparation of the microbial cultures 
Nutrient broth and Malt Extract broth were 
used to prepare media cultures of bacteria 
and yeast test microorganisms respectively. 
The Agar media were prepared according to 
the manufacturer's instructions. 
Approximately 10ml of autoclaved broth 
was aseptically transferred to sterile capped 
test tubes and then pure isolates of sub 
cultured bacteria and yeast colonies were 
aseptically transferred to the respective 
broth. By using the 0.5 McFarland 
standards, the bacteria and yeast number was 
adjusted to 1 x 10
6
c.f.u/ml. The bacteria or 
yeast cultures in respective tubes mixed with 
broth media were incubated for an overnight 
at 37± 1 °C for bacteria and for 48 hours at 
30°C for C. albicans. 
 
Antibacterial and antifungal activity tests 
Antibacterial activity of the crude extracts 
was determined by the Disc diffusion assay 
as described by Bauer et al. (1966). 
 
Nutrient Agar and Malt Extract Agar were 
prepared for bacteria and fungi respectively 
according to the manufacturer’s instructions. 
Immediately after autoclaving, the media 
was allowed to cool in a 45°C water bath. 
The freshly prepared and cooled media was 
mixed with suspension of microorganisms 
then poured into sterile polystyrene, flat-
bottomed Petri dishes placed on a level, 
horizontal surface (FASTER® Laminar flow 
to give a uniform distribution. The agar 
media was allowed to cool and solidify at 
room temperature.  
 
The Petri dishes were marked with spots 
placed almost equidistantly respective for 
each extract used in the test. Spots for 
positive and negative controls were also 
included in each petri dish. 
 
The discs were soaked into the dissolved 
crude extracts for a minimum of one hour. 
Standard discs of Ampicillin/Sulbactam 
(HiMedia Laboratories Pvt. Limited, 
Mumbai, India) for Gram-positive bacteria, 
Gentamicin (HiMedia Laboratories Pvt. 
Limited, Mumbai, India) for Gram-negative 
bacteria and Clotrimazole (HiMedia 
Laboratories Pvt. Limited, Mumbai, India) 
for C. albicans were used as positive 
controls at 10µg/ml. Negative control discs 
were soaked in dimethyl sulfoxide (DMSO) 
(Sigma, St. Louis, MO, USA) and distilled 
water for ethyl acetate and aqueous extracts 
respectively. 
 




Mill, Maidstone, Kent, England) were used 
in the disc diffusion method according to 
Faiza et al. (2011) and Lekshmi et al. 
(2012).  By use of a sterile forceps, the discs 
of the plant extracts and controls were 
placed equidistantly onto each on the 
inoculated petri dishes. The petri plates 
treated with extracts and/ or controls were 
stored in a refrigerator (DAEWOO
®
, 
Daewoo Electronics, Europe GmbH, 
Germany) at 4°C for six hours and thereafter 
transferred to incubator for 24 hours at 37° 




C for bacteria and for 48 hours at 30°C for 
C. albicans.  
 
The test was carried out in duplicates for 
each plant extract and repeated three times. 
Antimicrobial activities were determined by 
measuring the diameters of zones of 
inhibition in mm. The means, Activity index 
and standard deviations (±SD) of the 
diameters of zones of growth inhibitions for 
treatments were recorded.  
 
Activity index (AI) was calculated as = 
Inhibition zone of the test sample 
 Inhibition zone of a standard drug 
 
The minimum inhibitory concentration 
(MIC) is the lowest concentration of 
antimicrobial agent that completely inhibits 
growth of the organism in tubes or 
microdilution wells as detected by the un 
aided eye (Balouiri et al. 2016). The MIC 
was determined using standard broth 
dilution methods (Balouiri et al. 2016). 
Two-fold dilutions (0.05, 0.1, 0.2, 0.4, 0.8, 
1.6, 3.12, 6.2, 12.5, 25.0, 50.0, 100.0 mg/ml) 
of each of the plant extracts were prepared 
in a liquid growth medium and 100 µl 
dispensed in wells of a 96-well 
microtitration plate. Then, each well was 
inoculated with a 100 µl microbial inoculum 
prepared in the same medium after dilution 
of standardized microbial suspension 
adjusted to 0.5 McFarland scale. After well-
mixing, the inoculated 96-well microtitration 
plate were incubated without agitation at 
37
o
C for 24 hours. The extract blank (200 
µl) was also included for each concentration. 
The MIC endpoint was determined by using 
SPECTROstar Nano® plate reader from 
BMG LABTECH to facilitate reading 
microdilution tests and recording results 




Kruskal-Wallis analysis followed by Dunn’s 
pair-wise comparison test using GraphPad 
Prism software Version 6.0 were applied to 
determine the differences in sensitivities of 
microbes towards aqueous or ethyl acetate 
extracts treatments. A student t test was used 
to compare means of zones of inhibition for 




Six aqueous and five ethyl acetate plant 
crude extracts were tested for their growth 
inhibition activities on K. pneumoniae, S. 
lactis and C. albicans by using disc 
diffusion method. Positive controls were 
standard discs of Ampicillin/Sulbactam for 
S. lactis (Gram positive bacterium), 
Gentamicin for K. pneumonia (Gram 
negative bacterium) at a concentration of 10 
µg/ml and Clotrimazole for C. albicans. 
Negative control was DMSO for ethyl 
acetate extracts and distilled water for 
aqueous extracts. 
 
The results showed that indeed the six 
Tanzanian indigenous medicinal plant 
species tested under the current study have 
therapeutical potentials against different 
opportunistic infections in HIV/AIDS 
patients. Determination of the AI values 
(Table 1) and MIC values (Table 2) helped 
to form the basis of distinguishing active 
from non-active extracts.  
 
Streptococcus lactis: S. lactis was the most 
sensitive microorganism tested in this study. 
S. lactis growth was strongly inhibited by 
crude extracts from four different plant 
species, namely, ethyl acetate and water 
extracts of P. febrifugum, S. ellipticum, P. 
microcarpa and aqueous extract of T. nobilis 
with MICs ranging from 3.1 mg/ml to 100 
mg/ml (Table 2) and zones of inhibition as 
shown in Figures 1 and 2 
 
Klebsiella pneumonia: K. pneumonia growth 
was strongly inhibited by extracts from three 
plant, namely, ethyl acetate and aqueous 
extracts of S. ellipticum, ethyl acetate extract 
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of P. febrifugum and aqueous extract of T. 
nobilis, with MICs ranging from 6.2 mg/ml 
to 25 mg/ml (Table 2) and zones of 
inhibition as shown in Figures 1 and 2 
 
It is worthy noting that the activity of T. 
nobilis against both S. lactis and K. 
pneumonia was only concentrated in the 
ethyl acetate extracts. 
 
Candida albicans: Extracts from three plant 
species showed activity against C. albicans, 
these were: the ethyl acetate extracts of P. 
microcarpa and R. vomitoria, and the 
aqueous extract of H. madagascariensis 
with MICs ranging from 12.5 mg/ml to 50 
mg/ml (Table 2) and zones of inhibition as 
shown in Figures 1 and 2 
 
Note that extracts from R. vomitoria and H. 
madagascariensis showed activity only 





Figure 1: Growth inhibition of microbes by ethyl acetate extracts. Number of repeats n=3 and 
error bars represent standard deviation. EtAc – ethyl acetate; HM- Harungana 
madagascariensis, SE- Sapium ellipticum, TN- Teclea nobilis, PM- Pseudospondias 
microcarpa, RV- Rauvolfia vomitoria, and PF- Psorospermum febrifugum, Pos- 
Positive control were standard discs of Ampicillin/Sulbactam for gram positive bacteria, 
Gentamicin for gram negative bacteria at a concentration of 10 µg/ml and Clotrimazole 
for C. albicans. 






Figure 2: Growth inhibitions of microbes by aqueous extracts. Number of repeats n=3 and error 
bars represent standard deviation. Aq – aqueous extracts; HM- Harungana 
madagascariensis, SE- Sapium ellipticum, TN- Teclea nobilis, PM- Pseudospondias 
microcarpa, RV- Rauvolfia vomitoria, and PF- Psorospermum febrifugum, Pos- 
Positive control were standard discs of Ampicillin/Sulbactam for gram positive bacteria, 
Gentamicin for gram negative bacteria at a concentration of 10 µg/ml and Clotrimazole 
for C. albicans. 
 
Table 1: Activity index (AI) of crude extracts in the disc diffusion method.  
 










010 CMHS Aq 0.125 0.316 0.73 
Et 0.11 0.105 0.34 
Pseudospondias 
microcarpa 
012 CMHS Aq 0.80 0.46 0.00 
Et 0.81 0.47 0.57 
Psorospermum 
febrifugum 
005 CMHS Aq 0.82 0.34 0.0 
Et 1.36 0.51 0.47 
Sapium ellipticum 006 CMHS Aq 1.06 0.62 0.00 
Et 0.72 0.5 0.0 
Rauvolfia 
vomitoria 
003 CMHS Aq 0.33 0.29 0.467 
Et 0.413 0.27 0.633 
Teclea nobilis 002 CMHS Aq 0.62 0.73 0.0 
Et - - - 
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Although the aqueous extracts showed 
relatively higher activity than ethyl acetate 
extracts, the difference was statistically non-
significant. Comparison between means of 
the activity of the aqueous and that of ethyl 
acetate extract treatments gave no significant 
difference between the two treatments (t test 
p=0.6235). Also, the difference in sensitivity 
of different sensitive microbes treated with 
aqueous extracts was found to be non-
significant (Kruskal Wallis p value =0.082). 
Similarly, the difference on sensitivity of 
different sensitive microbes treated with 
ethyl acetate extracts was also not 
statistically significant (Kruskal Wallis p 
value =0.46).  
 
The concentration of extracts used was 
200mg/ml. Aq = aqueous, Et = Ethyl 
acetate. The higher the AI, the better the 
activity. If AI = 1, it means the activity of 
the extract is as good as the standard drug. 
 
 
Table 2: Minimum inhibitory concentrations (MICs) of aqueous and ethyl acetate extracts 
 
Extracts MIC (mg/ml) 
C. albicans K. pneumoniae S. lactis 
Harungana 
madagascariensis 
Aq 12.5 >100 >100 
EtAc >100 >100 >100 
Pseudospondias 
microcarpa 
Aq >100 >100 50 
EtAc 50 >100 25 
Psorospermum febrifugum Aq >100 >100 100 
EtAc >100 12.5 3.1 
Sapium ellipticum Aq >100 6.2 6.2 
EtAc >100 12.5      12.5 
Rauvolfia vomitoria Aq >100 >100 >100 
EtAc 25 >100 >100 
Teclea nobilis Aq >100 100         25 
EtAc >100 >100 >100 
 
DISCUSSION 
The results showed presence of 
antimicrobial activity in crude extracts from 
six indigenous medicinal plants against 
some microorganisms responsible in causing 
sickness in HIV/AIDS patients. 
Determination of AI values and MIC values 
helped to form the basis of distinguishing 
active from non-active extracts. These 
therapeutical potentials of the six plants 
against different opportunistic infections in 
HIV/AIDS patients could explain the wide 
use of the plants in traditional medicine for 
HIV/AIDS patients in Bukoba (Kisangau et 
al. 2007). 
 
S. lactis was the most sensitive 
microorganism tested in this study. This is 
the first ever study on the effect of the 
medicinal plants P. microcarpa, P. 
febrifegum and S. ellipticum on the probiotic 
food grade microorganism S. lactis. The 
extracts of these plants inhibited growth of 
the well-known serious opportunistic 
bacteria that cause life-threatening 
infections, which is also an important 
probiotic microorganism that has been 
shown to fight drug resistant Staphylococcus 
aureus (Wang et al. 2017). However, when 
such a complex combination of S. aureus 
and S. lactis infections happen on a victim, 
the later is known to be very resistant to 
drugs (Elliot and Facklam 1996, Mofredj et 




al. 2006, Mofredj et al. 2007), and standard 
treatment for infections caused by this 
microorganism (S. lactis) has not been well 
established (Karaaslan et al. 2016).  
 
A positive control in the present study 
against S. lactis (Ampicillin/Sulbactam) was 
not very active against S. lactis possibly 
because this microorganism is known to 
have natural resistance to some drug classes 
(Elliot and Facklam 1996, Mofredj et al. 
2007). The inhibition of S. lactis by these 
plant extracts in the current study is a break 
through and again emphasizes that plants 
might emerge the important sources of drugs 
against such notorious bacterium and also as 
a means to confer relief to HIV/AIDS 
patients. 
 
K. pneumonia growth was strongly inhibited 
by extracts from three plant, namely, ethyl 
acetate and aqueous extracts of S. ellipticum, 
ethyl acetate extract of P. febrifugum and 
aqueous extract of T. nobilis. The bacterial 
species had not been tested against the plants 
species before and so there is nothing to 
compare with the observation. The only two 
previous antimicrobial studies on the same 
plant species found the plant extracts to be 
active against bacterial species other than K. 
pneumoniae and S. lactis (Kisangau et al. 
2007, Onyancha et al. 2012). The two 
studies strongly suggest that the plants 
contain broad spectrum bioactive 
compounds, whose mechanisms of action 
may target different biochemical pathways 
of Gram-positive and Gram-negative 
pathogens (Rao et al. 2014). 
 
A gram negative K. pneumoniae which is a 
well-known resistant to many antibiotics on 
the market (Shaik 2014) has in this study 
portrayed sensitivity to some of the tested 
extracts with T. nobilis extracts being the 
most active against the bacterium with the 
AI of 0.73. Several studies have 
demonstrated the sensitivity of this bacterial 
species toward plants extracts (Cock and van 
Vuuren 2014, Araujo-junior et al. 2016, 
Winnett et al. 2017). The broad sensitivity of 
K. pneumoniae towards herbal medicines 
means that the possibility of discovering 
new effective drug to combat infections 
caused by this bacterium in plants is high.  
 
Extracts from only three plant species 
showed activity against C. albicans, these 
were:  the ethyl acetate extracts of P. 
microcarpa and R. vomitoria, and the 
aqueous extract of H. madagascariensis. 
The results are similar to the previous study 
by Kisangau et al. (2007) who also reported 
moderate sensitivity of C. albicans against 
these plant extracts. Though moderate, the 
activities of the tested plant extracts against 
C. Albicans observed in both studies suggest 
the presence of anti-fungal compounds in 
these plants. 
 
Although the aqueous extracts showed 
relatively higher activity than ethyl acetate 
extracts, the difference was statistically non-
significant and the result is similar to earlier 
studies (Kisangau et al. 2007, Sana and Ifra 
2012, Aneja et al. 2012). On the contrary, 
the ethyl acetate extracts showed non 
significantly more anti- Candida activity 
than the aqueous extracts; this may suggest 
that, the active anti- Candida active 
compounds in the extracts have lower 
polarity compared to ones present in 
aqueous extract.  
 
There is no literature available to explain the 
strong activity of the extracts of S. ellipticum 
and P. febrifegum. The finding may be 
interpreted that the two plant species contain 
strong broad-spectrum antimicrobial 
compounds. The aqueous extract of S. 
ellipticum and the ethyl acetate extract of P. 
febrifegum were slightly more active than 
the standard drugs used for S. lactis. And 
both the aqueous and ethyl acetate extracts 
of these two plants showed antibacterial 
activities, which could indicate that the 
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active components for the activity could be 
of both polar and non-polar nature. 
 
Note that extracts from R. vomitoria and H. 
madagascariensis showed activity only 
against the fungus C. albicans but no 
activity against the tested bacteria. It is 
worthy noting that the activity of T. nobilis 
against both S. lactis and K. pneumonia was 
only concentrated in the ethyl acetate 
extracts. In the absence of literature on any 
possible previous studies, explanation for 
such observations needs to be supported by 
further studies especially on the isolation of 
the active compounds from these plants. 
 
CONCLUSION 
The selected plants species in this study are 
used in the management of HIV/AIDS by 
the people of rural Bukoba, Tanzania, and in 
this study these plants have shown a 
promising therapeutic potential against 
microbial growth in vitro. Inhibition of 
microbial growth could be one of the many 
undocumented mechanism of therapeutic 
action of these plants in the management of 
HIV/AIDS. This is the first study to examine 
the effects of these Tanzanian medicinal 
plants on probiotic, often-neglected 
opportunistic microorganism such as S. 
lactis. More studies on neglected microbes 
should be encouraged. The choice of water 
is still the best in preparation of herbal 
extracts for human consumption mainly due 
to safety issues; in addition, this study has 
shown that aqueous extracts exhibited more 
activity than organic extracts. 
 
The findings provide a baseline information 
for further studies, especially in vivo studies 
in animal models, characterisation of the 
compounds responsible for and the 
mechanisms of the observed activites. 
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